Moonshot
Autor Albert Bourlaen Limba Engleză Hardback – 17 mar 2022
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 103.79 lei 3-5 săpt. | +17.11 lei 7-13 zile |
| HarperCollins Publishers – 17 mar 2022 | 103.79 lei 3-5 săpt. | +17.11 lei 7-13 zile |
| Hardback (1) | 138.27 lei 3-5 săpt. | +22.16 lei 7-13 zile |
| HarperCollins Publishers – 17 mar 2022 | 138.27 lei 3-5 săpt. | +22.16 lei 7-13 zile |
Preț: 138.27 lei
Nou
Puncte Express: 207
Preț estimativ în valută:
24.47€ • 28.69$ • 21.49£
24.47€ • 28.69$ • 21.49£
Carte disponibilă
Livrare economică 17-31 ianuarie 26
Livrare express 03-09 ianuarie 26 pentru 32.15 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780008503987
ISBN-10: 0008503982
Pagini: 288
Dimensiuni: 163 x 242 x 27 mm
Greutate: 0.5 kg
Editura: HarperCollins Publishers
ISBN-10: 0008503982
Pagini: 288
Dimensiuni: 163 x 242 x 27 mm
Greutate: 0.5 kg
Editura: HarperCollins Publishers
V-ar putea interesa
-
HBR Guide to Finance Basics for ManagersHarvard Business ReviewPreț: 109.79 lei -
Finance Basics (HBR 20-Minute Manager Series)Harvard Business ReviewPreț: 63.95 lei -
Creating Business Plans (HBR 20-Minute Manager Series)Harvard Business ReviewPreț: 64.97 lei
Notă biografică
Dr. Albert Bourla became Pfizer CEO in January 2019. He began his career at the company in 1993, in the Animal Health Division as Technical Director of Greece, and has served in numerous executive positions within the company, including Chief Operating Officer, Group President of Pfizer Innovative Health, and Group President of Pfizer's Global Vaccines, Oncology, and Consumer Healthcare business. He is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In addition to his responsibilities at Pfizer, Dr. Bourla is on the executive committee of The Partnership for New York City, a director on multiple boards, including Pfizer, Inc., PhRMA, and Catalyst, a Trustee of the United States Council for International Business, and a member of the Business Roundtable and the Business Council. In 2020, Dr. Bourla was named America's top CEO in the Pharmaceuticals sector by Institutional Investor magazine.